MME (psychedelic)
 | This article relies largely or entirely on a single source. (June 2019) |
| |
| Names | |
|---|---|
| Preferred IUPAC name
1-(5-Ethoxy-2,4-dimethoxyphenyl)propan-2-amine | |
| Other names
2,4-Dimethoxy-5-ethoxyamphetamine
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
MME (2,4-dimethoxy-5-ethoxyamphetamine) is a lesser-known psychedelic drug. It is a dimethoxy-ethoxy analog of TMA-2. MME was first synthesized by Alexander Shulgin from ethylvanillin. In his book PiHKAL, the minimum dosage is listed as 40 mg and above, and the duration listed as 6–10 hours.[1] Shulgin gives MME a ++ on the Shulgin Rating Scale.
Pharmacology
Shulgin describes in his book an experiment with MME, in which he admistered varying amounts of the drug to mice via injections.[1] Shulgin reports that 7 of the 9 mice injected with MME died as a result.[1] After describing his experiment, Shulgin speculates that MME may have an LD50 value of around 60–80 mg/Kg in mice when injected.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MME.
See also
References
- ^ a b c d MEM entry in PiHKAL
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |